Focused on early-stage investments, the manager has built a strong portfolio in the biotech and healthcare sectors. With deep experience in identifying disruptive technologies, they have successfully backed over 50 companies across North America and Europe. Known for a hands-on approach, they emphasize strategic support to drive rapid growth and capitalize on market opportunities. Their investment style combines rigorous due diligence with a commitment to fostering innovation, leading to numerous successful exits. Recognized as a top-tier fund manager, they leverage extensive industry networks to enhance portfolio performance.